Table 2 Serum levels of biomarkers in 92 patients with hand-arm vibration injury according to the severity of vascular manifestations graded by ICC 0–3 V.

From: Serum levels of biomarkers related to severity staging of Raynaud’s phenomenon, neurosensory manifestations, and vibration exposure in patients with hand-arm vibration injury

Biomarkers

ICC 0 V n = 47

ICC 1 V n = 7

ICC 2 V n = 9

ICC 3 V n = 19

P valuea

ICAM-1 (ng/mL)

170 (150–200)

180 (170–210)

170 (170–190)

170 (150–180)

0.59

MCP-1 (pg/mL)

39 (30–57)

41 (33–58)

42 (32–76)

36 (26–48)

0.50

TM (ng/mL)

5.2 (3.4–6.2)

5.1 (4.2–7.1)

8.7 (5.8–17)

6.1 (4.5–12)

0.01

vWf (µg/mL)

14 (6.9–34)

16 (7.6–23)

19 (11–20)

19 (16–21)

0.007

CGRP (pg/mL)

 < LODb (< LOD–96)

58 (< LOD–220)

140 (40–640)

94 (< LOD–300)

0.001

HSP27 (ng/ml)

2.8 (2.1–4.0)

2.8 (2.7–4.9)

3.4 (3.2–5.5)

3.6 (3.1–4.4)

0.007

Caspase-3 (ng/mL)

1.6 (1.0–2.5)

2.6 (1.1–3.6)

2.6 (1.8–24)

1.9 (1.4–7.2)

0.007

  1. aMedian (interquartile ranges).
  2. b10 individuals were excluded since they had not filled in hand diagram.
  3. cP values in boldface denotes statistically significant associations with Jonckheere-Tepstra trend test.
  4. dLimit of detection (LOD) 15 pg/ml.